Adjuvant chemotherapy with carmustine and cisplatin for patients with malignant gliomas
- 1 February 1992
- journal article
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 12 (2) , 131-135
- https://doi.org/10.1007/bf00172662
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarrazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final reportInternational Journal of Radiation Oncology*Biology*Physics, 1990
- Therapy of adult malignant brain tumors: what have the clinical trials taught us?1986
- Phase II Trial of Intracarotid BCNU and Cisplatin in Primary Malignant Brain TumorsCancer Drug Delivery, 1986
- Phase II study of cisplatin in recurrent astrocytomas in adults: A southwest oncology group studyJournal of Neuro-Oncology, 1983
- A pilot study of cis-diamminedichloroplatinum and radiation therapy in patients with high grade astrocytomasJournal of Neuro-Oncology, 1983
- HUMAN CENTRAL NERVOUS-SYSTEM DISTRIBUTION OF CIS-DIAMMINEDICHLOROPLATINUM AND USE AS A RADIOSENSITIZER IN MALIGNANT BRAIN-TUMORS1982
- Randomized Comparisons of Radiotherapy and Nitrosoureas for the Treatment of Malignant Glioma after SurgeryNew England Journal of Medicine, 1980
- Prediction of BCNU Pulmonary Toxicity in Patients with Malignant GliomasNew England Journal of Medicine, 1980
- Prognostic Factors for Survival in Patients With Inoperable Lung Cancer2JNCI Journal of the National Cancer Institute, 1980
- A Phase III comparison of BCNU, hydroxyurea, and radiation therapy to BCNU and radiation therapy for treatment of primary malignant gliomasJournal of Neurosurgery, 1979